Neurogene logo

Neurogene

NGNENASDAQ

Neurogene is a biotechnology company in the healthcare sector on NASDAQ, led by Rachel McMinn, with a market cap of $324.0M. As of Q3 2025, 107% of shares are held by 88 institutional investors, with Samsara BioCapital, LLC as the largest holder at 12.03%.

CEO of Neurogene, Inc.Rachel McMinn
Market Cap$324.0M
Biotechnology
Healthcare
Employees91.0
Country
United States of America

Overview

Overview of institutional ownership in NGNE as of Q3 2025 with a market cap of $247.3M

All Institutions

Institutions
88
Value Held
$265.2M
Shares Held
15.3M
Avg Position
$3.0M
Median Position
$229.7K

Hedge Funds

Hedge Funds
19
Value Held
$145.8M
Shares Held
8.4M
Avg Position
$7.7M
Median Position
$1.8M

Ownership Breakdown

Institutional (non-HF): 48.26%Institutional (non-HF)Hedge Funds: 58.95%Hedge FundsRetail & Other: -
Institutional (non-HF)
48.26%
$119.4M
Hedge Funds
58.95%
$145.8M
Retail & Other
-
-

Based on market cap of $247.3M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in NGNE as of Q3 2025

InstitutionPosition Value
$29.8M
3.89% of portfolio
RTW INVESTMENTS, LLC logo
RTW INVESTMENTS, LLC
Hedge FundSector
$23.6M
0.29% of portfolio
R
Redmile Group, LLC
Hedge FundSector
$22.5M
2.19% of portfolio
Casdin Capital, LLC logo
Casdin Capital, LLC
Hedge FundSector
$22.4M
1.94% of portfolio
EcoR1 Capital, LLC logo
EcoR1 Capital, LLC
Hedge FundSector
$22.0M
1.06% of portfolio
B
BAKER BROS. ADVISORS LP
Hedge FundSector
$17.2M
0.16% of portfolio
B
BlackRock, Inc.
Institution
$16.5M
0.00% of portfolio
BALYASNY ASSET MANAGEMENT LLC logo
BALYASNY ASSET MANAGEMENT LLC
Hedge FundMulti-Strategy
$12.1M
0.03% of portfolio
$11.8M
0.02% of portfolio
$10.5M
0.00% of portfolio

Net Capital Flow

Institutional buying and selling activity for NGNE in Q3 2025

Traded
$148.7K
Buyers
40
Sellers
36
Total Bought
+$21.8M
Total Sold
$22.0M
Avg Position
$2.7M

Biggest Buyers

InstitutionNet Bought
BALYASNY ASSET MANAGEMENT LLC logo
BALYASNY ASSET MANAGEMENT LLC
Hedge FundMulti-Strategy
+$12.1M
+699.0K shares
JENNISON ASSOCIATES LLC logo
JENNISON ASSOCIATES LLC
Long Only Manager
+$3.9M
+226.5K shares
+$1.1M
+62.4K shares
+$961.9K
+55.5K shares
Trexquant Investment LP logo
Trexquant Investment LP
Hedge FundQuant
+$684.2K
+39.5K shares
ExodusPoint Capital Management, LP logo
ExodusPoint Capital Management, LP
Hedge FundMulti-Strategy
+$563.6K
+32.5K shares
R
Redmile Group, LLC
Hedge FundSector
+$387.3K
+22.3K shares
+$292.0K
+16.8K shares
+$236.2K
+13.6K shares
+$223.2K
+12.9K shares

Biggest Sellers

InstitutionNet Sold
COMMODORE CAPITAL LP logo
COMMODORE CAPITAL LP
Hedge FundLong/Short
$6.4M
427.9K shares
FMR LLC logo
FMR LLC
Institution
$6.1M
352.9K shares
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
$2.1M
119.0K shares
MILLENNIUM MANAGEMENT LLC logo
MILLENNIUM MANAGEMENT LLC
Hedge FundMulti-Strategy
$1.0M
59.9K shares
$950.5K
54.8K shares
Octagon Capital Advisors LP logo
Octagon Capital Advisors LP
Hedge FundSector
$883.8K
51.0K shares
$676.6K
39.0K shares
$671.3K
44.9K shares
UBS OCONNOR LLC logo
UBS OCONNOR LLC
Long Only Manager
$519.7K
34.8K shares
R
READYSTATE ASSET MANAGEMENT LP
Hedge FundMulti-Strategy
$474.1K
31.7K shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited NGNE in Q3 2025

New Positions
7
New Value
$13.3M
Exited Positions
10
Exited Value
$8.8M

New Positions

InstitutionPosition Value
BALYASNY ASSET MANAGEMENT LLC logo
BALYASNY ASSET MANAGEMENT LLC
Hedge FundMulti-Strategy
$12.1M
699.0K shares
Trexquant Investment LP logo
Trexquant Investment LP
Hedge FundQuant
$684.2K
39.5K shares
$292.0K
16.8K shares
$186.8K
10.8K shares
Point72  Ltd logo
Point72 Ltd
RIA/Wealth
$14.5K
835.0 shares
$1.3K
76.0 shares
$277.0
16.0 shares

Exited Positions

InstitutionPrevious Position
COMMODORE CAPITAL LP logo
COMMODORE CAPITAL LP
Hedge FundLong/Short
$6.4M
427.9K shares
$671.3K
44.9K shares
UBS OCONNOR LLC logo
UBS OCONNOR LLC
Long Only Manager
$519.7K
34.8K shares
R
READYSTATE ASSET MANAGEMENT LP
Hedge FundMulti-Strategy
$474.1K
31.7K shares
$388.8K
26.0K shares
H
$321.2K
21.5K shares
$6.5K
437.0 shares
$6.1K
405.0 shares
$120.0
8.0 shares
$96.0
5.0 shares

Options Activity

Institutions with the largest Call and Put options positions in NGNE as of Q3 2025

Call Positions
2
Call Value
$403.8K
Put Positions
1
Put Value
$208.0K

Call Positions

InstitutionPosition Value
$403.8K
233.0 contracts
-
- contracts

Put Positions

InstitutionPosition Value
$208.0K
120.0 contracts

Most Committed Institutions

Institutions with NGNE as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
3.89%
$29.8M
3.41%
$7.7M
R
Redmile Group, LLC
Hedge FundSector
2.19%
$22.5M
Casdin Capital, LLC logo
Casdin Capital, LLC
Hedge FundSector
1.94%
$22.4M
EcoR1 Capital, LLC logo
EcoR1 Capital, LLC
Hedge FundSector
1.06%
$22.0M
Octagon Capital Advisors LP logo
Octagon Capital Advisors LP
Hedge FundSector
0.69%
$4.4M
RTW INVESTMENTS, LLC logo
RTW INVESTMENTS, LLC
Hedge FundSector
0.29%
$23.6M
A
Arrowpoint Asset Management, LLC
Hedge FundMulti-Strategy
0.19%
$10.3M
B
BAKER BROS. ADVISORS LP
Hedge FundSector
0.16%
$17.2M
D
DAFNA Capital Management LLC
Hedge FundEvent Driven
0.13%
$526.4K

Hedge Fund Spotlight

Discover hedge funds investing in NGNE

Portfolio ManagerNnamdi C Etoh
Portfolio Value
$1.7B
Positions
91
Last Reported
Q3 2025
AddressBaltimore, MD
Sector Allocation
Healthcare: 81.80%HealthcareETF: 0.90%
Neurogene logo

Position in Neurogene

Market Value
$1.8M
Shares Held
104.3K
Portfolio Weight
0.11%
Owned Since
2024-Q4
Top HoldingSectorMarket ValueWeight
1
ARGX
argenx
ARGX
Unknown
Unknown
$105.3M6.18%
Drug Manufacturers - General
Healthcare
$80.4M4.72%
Biotechnology
Healthcare
$72.4M4.25%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.